168 related articles for article (PubMed ID: 35715142)
21. Undifferentiated pleomorphic sarcoma with co-existence of KRAS/PIK3CA mutations.
Li B; Li L; Li X; Wang Y; Xie Y; Liu C; Li F
Int J Clin Exp Pathol; 2015; 8(7):8563-7. PubMed ID: 26339434
[TBL] [Abstract][Full Text] [Related]
22. Systematic screening identifies a 2-gene signature as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma.
Hu Q; Zhou S; Hu X; Zhang H; Huang S; Wang Y
J Cell Mol Med; 2020 Jan; 24(1):1010-1021. PubMed ID: 31742892
[TBL] [Abstract][Full Text] [Related]
23. What is an adequate margin for infiltrative soft-tissue sarcomas?
Fujiwara T; Stevenson J; Parry M; Tsuda Y; Tsoi K; Jeys L
Eur J Surg Oncol; 2020 Feb; 46(2):277-281. PubMed ID: 31627932
[TBL] [Abstract][Full Text] [Related]
24. Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Akiyama T; Sugaya J; Nakatani F; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2022 Jan; 35(1):384-391. PubMed ID: 34665443
[TBL] [Abstract][Full Text] [Related]
25. Does pre-operative MRI predict the risk of local recurrence in primary myxofibrosarcoma of the extremities?
Sambri A; Spinnato P; Bazzocchi A; Tuzzato GM; Donati D; Bianchi G
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e181-e186. PubMed ID: 31111597
[TBL] [Abstract][Full Text] [Related]
26. Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma.
Williams EA; Vegas I; El-Senduny FF; Zhang J; Mata DA; Hiemenz MC; Hughes SR; Sa BC; Kraft GP; Gorbatov N; Foley-Peres K; Sanchez EZ; Milikowski C; Williams KJ; Ross JS; Kurzrock R; Montgomery EA; Lombard DB; Kumar S
Am J Surg Pathol; 2024 Jun; 48(6):699-707. PubMed ID: 38369783
[TBL] [Abstract][Full Text] [Related]
27. Overview of malignant soft-tissue sarcomas of the limbs.
Renn A; Adejolu M; Messiou C; Bhaludin B; Strauss DC; Thway K; Moskovic E
Clin Radiol; 2021 Dec; 76(12):940.e1-940.e16. PubMed ID: 34607656
[TBL] [Abstract][Full Text] [Related]
28. Myxoid malignant fibrous histiocytoma presenting as a midline nasal mass.
DeRosa J; Smit JR
Ear Nose Throat J; 2012 Apr; 91(4):E3-5. PubMed ID: 22522364
[TBL] [Abstract][Full Text] [Related]
29. Compartmental resection for subfascial extremity soft tissue sarcoma and quality of life in long-term survivors.
Peiper M; Matthaei H; Bölke E; Zurakowski D; Orth K; Heinecke A; Knoefel WT
Wien Klin Wochenschr; 2011 Aug; 123(15-16):488-95. PubMed ID: 21739209
[TBL] [Abstract][Full Text] [Related]
30. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
Soleymani T; Tyler Hollmig S
Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
[TBL] [Abstract][Full Text] [Related]
31. Metastatic undifferentiated pleomorphic sarcoma causing intraoperative stroke.
Spaulding R; Koumoundouros T; Parker JC
Ann Clin Lab Sci; 2013; 43(2):172-5. PubMed ID: 23694792
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.
Roland CL; May CD; Watson KL; Al Sannaa GA; Dineen SP; Feig R; Landers S; Ingram DR; Wang WL; Guadagnolo BA; Feig B; Hunt KK; Cormier JN; Lazar AJ; Torres KE
Ann Surg Oncol; 2016 Jul; 23(7):2220-8. PubMed ID: 26847678
[TBL] [Abstract][Full Text] [Related]
33. Biology, classification, and management of recurrent myxofibrosarcoma 21 years after resection.
Palumbo BT; Henderson E; Letson GD; Cheong D
Am J Orthop (Belle Mead NJ); 2011 Nov; 40(11):579-82. PubMed ID: 22263212
[TBL] [Abstract][Full Text] [Related]
34. The clinical outcomes of undifferentiated pleomorphic sarcoma (UPS): A single-centre experience of two decades with the assessment of PD-L1 expressions.
Lee K; Song JS; Kim JE; Kim W; Song SY; Lee MH; Chung HW; Cho KJ; Lee JS; Ahn JH
Eur J Surg Oncol; 2020 Jul; 46(7):1287-1293. PubMed ID: 32127249
[TBL] [Abstract][Full Text] [Related]
35. Myxofibrosarcoma (myxoid malignant fibrous histiocytoma) showing cutaneous presentation: report of two cases.
Fujimura T; Okuyama R; Terui T; Okuno K; Masu A; Masu T; Chiba S; Kunii T; Tagami H; Aiba S
J Cutan Pathol; 2005 Aug; 32(7):512-5. PubMed ID: 16008697
[TBL] [Abstract][Full Text] [Related]
36. Malignant fibrous histiocytoma of soft tissue: an abandoned diagnosis.
Randall RL; Albritton KH; Ferney BJ; Layfield L
Am J Orthop (Belle Mead NJ); 2004 Dec; 33(12):602-8. PubMed ID: 15641745
[TBL] [Abstract][Full Text] [Related]
37. Undifferentiated pleomorphic sarcoma of the orbital region: a case report.
Cruz NFSD; Matsuno CA; Cruz SFSD; Miranda AP; Vital Filho J
Arq Bras Oftalmol; 2018 Apr; 81(2):153-156. PubMed ID: 29846420
[TBL] [Abstract][Full Text] [Related]
38. [Malignant fibrous histiocytoma of the penis].
Crisman G; Margiotta G; Calabresi M; Discepoli S; Leocata P
Pathologe; 2015 Jul; 36(4):385-8. PubMed ID: 26055331
[TBL] [Abstract][Full Text] [Related]
39. Pleomorphic sarcoma of maxillary sinus: Clinical report of a patient initially diagnosed with denture-induced fibrous hyperplasia.
Valente VB; Kayahara GM; Bastos DB; Santos IDS; Xavier-Junior JCC; Biasoli ÉR; Miyahara GI; Bernabé DG
J Prosthet Dent; 2022 Oct; 128(4):548-553. PubMed ID: 33875263
[TBL] [Abstract][Full Text] [Related]
40. The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray study.
Lahat G; Zhang P; Zhu QS; Torres K; Ghadimi M; Smith KD; Wang WL; Lazar AJ; Lev D
Histopathology; 2011 Sep; 59(3):556-61. PubMed ID: 22034893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
